The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
- PMID: 34063231
- PMCID: PMC8124491
- DOI: 10.3390/ijms22094830
The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
Abstract
Cancer and viruses have a long history that has evolved over many decades. Much information about the interplay between viruses and cell proliferation and metabolism has come from the history of clinical cases of patients infected with virus-induced cancer. In addition, information from viruses used to treat some types of cancer is valuable. Now, since the global coronavirus pandemic erupted almost a year ago, the scientific community has invested countless time and resources to slow down the infection rate and diminish the number of casualties produced by this highly infectious pathogen. A large percentage of cancer cases diagnosed are strongly related to dysregulations of the tyrosine kinase receptor (TKR) family and its downstream signaling pathways. As such, many therapeutic agents have been developed to strategically target these structures in order to hinder certain mechanisms pertaining to the phenotypic characteristics of cancer cells such as division, invasion or metastatic potential. Interestingly, several authors have pointed out that a correlation between coronaviruses such as the SARS-CoV-1 and -2 or MERS viruses and dysregulations of signaling pathways activated by TKRs can be established. This information may help to accelerate the repurposing of clinically developed anti-TKR cancer drugs in COVID-19 management. Because the need for treatment is critical, drug repurposing may be an advantageous choice in the search for new and efficient therapeutic compounds. This approach would be advantageous from a financial point of view as well, given that the resources used for research and development would no longer be required and can be potentially redirected towards other key projects. This review aims to provide an overview of how SARS-CoV-2 interacts with different TKRs and their respective downstream signaling pathway and how several therapeutic agents targeted against these receptors can interfere with the viral infection. Additionally, this review aims to identify if SARS-CoV-2 can be repurposed to be a potential viral vector against different cancer types.
Keywords: EGFR; coronavirus; pandemic; receptor; signaling pathway; tyrosine kinase.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.Comput Biol Med. 2021 Jan;128:104123. doi: 10.1016/j.compbiomed.2020.104123. Epub 2020 Nov 24. Comput Biol Med. 2021. PMID: 33260034 Free PMC article.
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27466418 Free PMC article.
-
Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.Med Res Rev. 2021 May;41(3):1375-1426. doi: 10.1002/med.21763. Epub 2020 Dec 5. Med Res Rev. 2021. PMID: 33277927 Free PMC article. Review.
-
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.J Virol. 2021 Jan 28;95(4):e01622-20. doi: 10.1128/JVI.01622-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33219167 Free PMC article.
Cited by
-
Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α).Phytother Res. 2022 Jul;36(7):2679-2682. doi: 10.1002/ptr.7440. Epub 2022 Mar 20. Phytother Res. 2022. PMID: 35307904 Free PMC article. No abstract available.
-
Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2.iScience. 2023 Aug 19;26(9):107690. doi: 10.1016/j.isci.2023.107690. eCollection 2023 Sep 15. iScience. 2023. PMID: 37680484 Free PMC article.
-
A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2.Res Sq [Preprint]. 2022 Mar 21:rs.3.rs-1474136. doi: 10.21203/rs.3.rs-1474136/v1. Res Sq. 2022. Update in: Front Immunol. 2022 Jul 01;13:918817. doi: 10.3389/fimmu.2022.918817. PMID: 35434729 Free PMC article. Updated. Preprint.
-
Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.Vaccines (Basel). 2022 Aug 3;10(8):1248. doi: 10.3390/vaccines10081248. Vaccines (Basel). 2022. PMID: 36016137 Free PMC article.
-
Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases.Viruses. 2023 Feb 19;15(2):568. doi: 10.3390/v15020568. Viruses. 2023. PMID: 36851782 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous